Assessment for the Correlation Between Diabetic Retinopathy and Metabolic Syndrome: A Cross-Sectional Study

References

• Cheung N , Mitchell P , Wong TY . Diabetic retinopathy. Lancet . 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3 20580421
   PubMed Web of Science ®Google Scholar
• Wilkinson CP , Ferris FL 3rd , Klein RE , et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology . 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5 13129861
   PubMed Web of Science ®Google Scholar
• Kollias AN , Ulbig MW . Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int . 2010;107(5):75–83; quiz 84. doi:10.3238/arztebl.2010.0075
   Web of Science ®Google Scholar
• Vision Health Initiative (VHI) Report. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus United States, 2005–2050. In: Centers for Disease Control and Prevention. Centers for Disease Control and Prevention . Atlanta, GA; 2015.
   Google Scholar
• Wong TY , Mwamburi M , Klein R , et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care . 2009;32(12):2307–2313. doi:10.2337/dc09-0615 19940227
   PubMed Web of Science ®Google Scholar
• Reaven GM . Banting lecture 1988. Role of insulin resistance in human disease. Diabetes . 1988;37(12):1595–1607. doi:10.2337/diab.37.12.1595 3056758
   PubMed Web of Science ®Google Scholar
• Feinkohl I , Janke J , Hadzidiakos D , et al. Associations of the metabolic syndrome and its components with cognitive impairment in older adults. BMC Geriatr . 2019;19(1):77. doi:10.1186/s12877-019-1073-7 30845934
   PubMed Web of Science ®Google Scholar
• O’Neill S , O’Driscoll L . Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev . 2015;16(1):1–12. doi:10.1111/obr.12229
   PubMed Web of Science ®Google Scholar
• Després JP , Lemieux I . Abdominal obesity and metabolic syndrome. Nature . 2006;444(7121):881–887. doi:10.1038/nature05488 17167477
   PubMed Web of Science ®Google Scholar
• Eckel RH , Grundy SM , Zimmet PZ . The metabolic syndrome. Lancet . 2005;365(9468):1415–1428. doi:10.1016/S0140-6736(05)66378-7 15836891
   PubMed Web of Science ®Google Scholar
• Dunston DW , Zimmet PZ , Wellborn TA . The rising prevalence of diabetes and 1GT. The American diabetes, obesity and lifestyle study. Diabetes Care . 2002;25:829–834. doi:10.2337/diacare.25.5.829 11978676
   PubMed Web of Science ®Google Scholar
• Isomaa B , Almgren P , Tuomi T , et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care . 2001;24(4):683–689. doi:10.2337/diacare.24.4.683 11315831
   PubMed Web of Science ®Google Scholar
• Saely CH , Aczel S , Marte T , Langer P , Hoefle G , Drexel H . The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab . 2005;90(10):5698–5703. doi:10.1210/jc.2005-0799 16091486
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention National Center for Health Statistics. National health and nutrition examination survey 1988–1994, 2005–2006, and 2007–2008 questionnaires, datasets and related documentation. Available from: https://wwwn.cdc.gov/nchs/nhanes/Default.aspx. Accessed 12 2, 2019.
   Google Scholar
• Nhanes Digital Grading Protocol: Centers for disease control and prevention. Available from: https://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/NHANES_ophthamology_digital_grading_protocol.pdf. Accessed 12 2, 2019.
   Google Scholar
• Alberti K , Eckel RH , Grundy SM , et al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation . 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644 19805654
   PubMed Web of Science ®Google Scholar
• Wood SN . Generalized additive models: an introduction with R; Chapman and Hall/CRC. FL, USA: Boca Raton; 2006.
   Google Scholar
• Wild S , Roglic G , Green A , Sicree R , King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care . 2004;27(5):1047–1053. doi:10.2337/diacare.27.5.1047 15111519
   PubMed Web of Science ®Google Scholar
• Wong TY , Duncan BB , Golden SH , et al. Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Invest Ophthalmol Vis Sci . 2004;45(9):2949–2954. doi:10.1167/iovs.04-0069 15326106
   PubMed Web of Science ®Google Scholar
• Bragd J , Adamson U , Backlund LB , Lins PE , Moberg E , Oskarsson P . Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab . 2008;34(6 Pt 1):612–616. doi:10.1016/j.diabet.2008.04.005 18824382
   PubMed Web of Science ®Google Scholar
• Sartore G , Chilelli NC , Burlina S , Lapolla A . Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol . 2013;50(3):437–442. doi:10.1007/s00592-013-0459-9 23417155
   PubMed Web of Science ®Google Scholar
• Gimeno-Orna JA , Castro-Alonso FJ , Boned-Juliani B , Lou Arnal LM . Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. J Diabetes Complications . 2003;17(2):78–81. doi:10.1016/S1056-8727(02)00197-6 12614973
   PubMed Web of Science ®Google Scholar
• Hirakawa Y , Arima H , Zoungas S , et al. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care . 2014;37(8):2359–2365. doi:10.2337/dc14-0199 24812434
   PubMed Web of Science ®Google Scholar
• Takao T , Ide T , Yanagisawa H , Kikuchi M , Kawazu S , Matsuyama Y . The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. Diabetes Res Clin Pract . 2010;89(3):296–302. doi:10.1016/j.diabres.2010.03.027 20416966
   PubMed Web of Science ®Google Scholar
• Takao T , Ide T , Yanagisawa H , Kikuchi M , Kawazu S , Matsuyama Y . The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients. Diabetes Res Clin Pract . 2011;91(2):e40–e42. doi:10.1016/j.diabres.2010.10.009 21035886
   PubMed Web of Science ®Google Scholar
• Cardoso CRL , Leite NC , Moram CBM , Salles GF . Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc Diabetol . 2018;17(1):33. doi:10.1186/s12933-018-0677-0 29477146
   PubMed Web of Science ®Google Scholar
• Takao T , Inoue K , Suka M , Yanagisawa H , Iwamoto Y . Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: a longitudinal study over 27years. Diabetes Res Clin Pract . 2018;140:228–235. doi:10.1016/j.diabres.2018.03.051 29625141
   PubMed Web of Science ®Google Scholar
• Li W , Liu X , Yanoff M , Cohen S , Ye X . Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia . 1996;39(5):537–547. doi:10.1007/BF00403300 8739913
   PubMed Web of Science ®Google Scholar
• Perrott RL , North RV , Drasdo N , Ahmed KA , Owens DR . The influence of plasma glucose upon pulsatile ocular blood flow in subjects with type II diabetes mellitus. Diabetologia . 2001;44(6):700–705. doi:10.1007/s001250051678 11440362
   PubMed Web of Science ®Google Scholar
• Boussageon R , Bejan-Angoulvant T , Saadatian-Elahi M , et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomized controlled trials. BMJ . 2011;343:d4169. doi:10.1136/bmj.d4169 21791495
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet . 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6 9742976
   PubMed Web of Science ®Google Scholar
• Foo V , Quah J , Cheung G , et al. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics. J Diabetes . 2017;9(2):200–207. doi:10.1111/1753-0407.12403 27043025
   PubMed Web of Science ®Google Scholar
• Pang C , Jia L , Jiang S , et al. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: shanghai diabetic complications study. Diabetes-Metab Res . 2012;28(3):276–283. doi:10.1002/dmrr.1307
   PubMed Web of Science ®Google Scholar
• Sasso FC , Pafundi PC , Gelso A , et al. Telemedicine for screening diabetic retinopathy: the no BLIND Italian multicenter study. Diabetes-Metab Res . 2019;35(3):e3113.
   Web of Science ®Google Scholar
• Minutolo R , Sasso FC , Chiodini P , et al. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings. J Hypertens . 2006;24(8):1655–1661. doi:10.1097/01.hjh.0000239303.93872.31 16877970
   PubMed Web of Science ®Google Scholar
• Benedetti A , Abrahamowicz M . Using generalized additive models to reduce residual confounding. Stat Med . 2004;23(24):3781–3801. doi:10.1002/sim.2073 15580601
   PubMed Web of Science ®Google Scholar
• Moore L , Hanley JA , Turgeon AF , Lavoie A . A comparison of generalized additive models to other common modeling strategies for continuous covariates: implications for risk adjustment. J Biometrics Biostat . 2011;2(1):1000109.
   Google Scholar